SLC34A2 and skin cancer: The comparisons of SLC34A2 expression between healthy and tumor tissues showed a distinction in their expression level: upregulation was found in samples of myeloid, bowel, ovarian, and uterine tumors; downregulation was found in tumor samples of breast, liver, lung, and skin cancer tumors.